AA
Andreas Argyrides Oppenheimer Latest Price Targets & Analyst Ratings
Main Sector
Healthcare
Ratings Past Year
28
Avg Return
Past Year
Past Year
24%
Success Rate
Past Year
Past Year
0
%
Rating Distribution
Past 3 Months
Positive
83.3%
Neutral
16.7%
Negative
0%
Past Week
Past Month
Past 3 Months
Past 6 Months
Past Year
All Time
Positive
Neutral
Negative
Large Cap
$10B to $200B
Mid Cap
$2B to $10B
Small Cap
$250M to $2B
Micro Cap
Under $250M
Healthcare
Healthcare
Biotechnology
Drug Manufacturers - General
Drug Manufacturers - Specialty & Generic
| Stock | Rating | Price Target |
Upside Downside |
Ratings 3 Months |
Avg Return 1 Year |
Success Rate 1 Year | Date | |
|---|---|---|---|---|---|---|---|---|
|
Outperform
Maintained
| $9 |
43%
upside
| 2 | +31% |
0
%
| 14 Nov ‘25 19 days ago |
|
|
|
Outperform
Reiterated
| $27 |
49%
upside
| 1 | -12% |
0
%
| 12 Nov ‘25 21 days ago |
|
|
|
Perform
Maintained
| $11 |
45%
downside
| 2 | +14% |
0
%
| 12 Nov ‘25 21 days ago |
|
|
|
Outperform
Maintained
| $115 |
49%
upside
| 2 | +70% |
0
%
| 2 Oct ‘25 2 months ago |
|
|
|
Outperform
Maintained
| $21 |
505%
upside
| 1 | -16% |
0
%
| 2 Oct ‘25 2 months ago |
|
|
|
Outperform
Maintained
| $29 |
131%
upside
| 1 | -8.2% |
0
%
| 16 Sep ‘25 2 months ago |
|
|
|
Outperform
Maintained
| $33 |
3,468%
upside
| 1 | +108% |
0
%
| 11 Sep ‘25 2 months ago |
|
|
|
Outperform
Maintained
| $575 |
20%
upside
| 1 | +26% |
0
%
| 5 Sep ‘25 2 months ago |
|
|
|
Outperform
Maintained
| $15 |
168%
upside
| 1 | +4.7% |
0
%
| 5 Sep ‘25 2 months ago |
|